Advanced searches left 3/3
Search only database of 8 mil and more summaries

Pet Scan For Lungs

Summarized by PlexPage
Last Updated: 02 July 2021

* If you want to update the article please login/register

General | Latest Info

Lung Cancer occurs when certain cells within the lung grow in an uncontrolled, abnormal, manner. There are two major categories of lung cancersmall cell lung Cancer and non - small cell lung Cancer. Lung Cancer is the leading cause of cancer death in the United States. According to the American Cancer Society, more than 221 000 patients will be diagnosed with lung Cancer and nearly 157 000 will die from the disease in 2011. Molecular imaging is playing an increasingly important role in detection, diagnosis and treatment of NSCLC, which accounts for the majority of lung cancer cases. Treatment options for NSCLC include chemotherapy and radiation and, if diagnosed early enough, surgery. Accurately identifying if cancer has spread to other parts of the body is critical for determining treatment options for patients. In future, scientists anticipate that molecular imaging procedures will be increasingly used to evaluate disease progression, assess treatment strategies and monitor treatment effects. Technologies currently used to diagnose and treat non - small cell lung cancer include p_ositron emission tomography and combination PET and compute tomography.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Advantages of PET

Pet / CT scan combines two different types of imaging scans during a single procedure with one machine. This technologically advanced screening combines two distinctive technologies to reveal critical information about the function and form of cells and organs inside the body. Positron emission tomography is a nuclear imaging technique that uses radioactive tracers that are ingested or injected and then absorbed by body tissue. Scan will show areas of greater absorption, which may indicate disease. Pet scans can provide details about how well blood or oxygen travels throughout the body, how well sugar is process, and more. Pet scan may reveal cancerous tissue not revealed by CAT scan. Compute tomography utilizes X - rays taken from different angles and then processed by computer to create a 3D, cross - sectional image of the body. Ct scans produce more accurate and precise images than X - rays. These scans can reveal the size, shape and location of the tumor, as well as blood vessels feeding it. Combine PET / CT scans provide information from a single imaging session about cells, structures, and functioning of body tissues and organs, providing more robust diagnosis than either scan can produce independently. There are more advantages to having PET / CT scan than are disadvantages. What follows are some of the pros and cons of having this combined imaging procedure.


Advantages of a PET/CT Scan

Clinical research has shown that in comparison to PET scan alone, PET / CT technology provides new information that can alter patient's treatment plan to better target cancer in approximately one - third of cases. In one example, PET / CT scan of a lung cancer patient revealed not only the original tumor in the lungwhich previous CT scan had foundbut additional tumor CT miss: small, early stage lesion in the neck. Base on CT alone, doctor would have recommended surgery, but additional tumors found by PET / CT indicated that cancer had spread and was inoperable. Base on this information, doctors proceed with radiation therapy, giving patients a better chance of survival.


What is a PET scan?

According to an article published in Journal of Nuclear Medicine, whole - body positron emission tomography appears to be more accurate than conventional imaging in predicting risk of recurrences in breast cancer patients. Imaging procedures that are often utilized prior to and following treatment to determine where cancer may exist in the body include computerized tomography scans, X - rays, sonography, magnetic resonance imaging, mammography and bone scans. More recently, PET scans have been utilized and appear to have superior imaging to more conventional scans for various cancers. Researchers from Sacramento evaluate accuracy of PET scans in determining risk of recurrences in patients who have been recently treated for breast cancer. In this study, 61 patients were evaluated on average 4 years following their last treatment. Patients were first evaluated with CT scans, X - ray, MRI, mammography, bone scans and sonography and then re - evaluated with one whole - body PET scan. Pet scan accurately determines the outcome of 90% of patients, while combination of all conventional images accurately determines the outcome of only 75% of patients. Of patients in which there was discrepancy between PET scan and other imagings PET correctly predicted the outcome of 80% of patients while conventional imaging correctly predicted the outcome of only 20%. These results appear to indicate that one whole - body PET scan may more accurately predict risk of recurrence than multiple conventional imagings in patients recently treated for breast cancer. This may allow patients to receive more appropriate follow - up treatment in order to provide optimal chances for long - term survival or cure. Medicaid and Medicare have recently approved reimbursement for PET scans in women with breast cancer. Reimbursement includes staging for distant metastases, restaging patients with local recurrences or metastasis and determining treatment response. Patients with breast cancer may wish to speak with their physician about utilization of whole - body PET scan.


How does the procedure work?

Nuclear medicine imaging is performed on outpatients and hospitalized patients. You will lie on the examination table. If necessary, nurse or technologist will insert an intravenous catheter into a vein in your hand or arm. A Radiotracer typically takes about 30 - 60 minutes to travel through your body and be absorbed by the area under examination. You will be asked to rest quietly and to avoid movement and talking. You may be asked to drink some contrast material that will localize in intestines and help radiologist interpret exam. You will be moved into PET / CT scanner to begin imaging. You will need to remain still during imaging. The Ct exam takes place first, followed by a PET scan. On occasion, second CT scan with intravenous contrast will follow the PET scan. For more information on how CT scanning is perform, see compute Tomography. A CT scan takes less than two minutes. A PET scan takes 20 - 30 minutes. Depending on which area is under examination, additional tests involving other tracers or drugs may be used. This could lengthen procedure time to three hours. For example, if you are examined for heart disease, you may undergo a PET scan both before and after exercising or before and after receiving IV medication that increases blood flow to the heart. When the examination is complete, you may be asked to wait until the technologist checks images in case more images are needed. Sometimes, more images are obtained to clarify or better visualize certain areas or structures. The need for more images does not necessarily mean there was problem with the exam or that something abnormal was find. It should not cause you concern. If you had intravenous line inserted for procedure, it will usually be removed unless you are scheduled for another procedure that same day that requires IV line.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Results

An Unadjusted pool analysis of 70 studies shows evidence of significant heterogeneity among studies in sensitivity, and specificity. Pooled sensitivity of FDG - PET for diagnosing lung cancer was 89% and pooled specificity was 75%. Ten studies reporting endemic disease had unadjusted pooled specificity of 54% 10 11 14 15 24 - 29 compared with 78% in the remaining 60 studies. Asymmetry test does not show evidence of publication bias. No trend over time or between periods in diagnostic accuracy was observe. A random - effects model that includes random intercept for each study and various fixed effects for study characteristics was used to account for observed heterogeneity. The model yielded an average adjusted estimate of sensitivity of 89% and specificity of 75% 30 - 89. Area under HSROC curve was 0. 90. Pis shows an extreme amount of heterogeneity among studies that remains after adjusting for study characteristics. Sensitivity of randomly chosen study was predicted at 89% and specificity was 75%. Similar increases in PI length were observed for all analyses. Results present in the following sections are adjusted results from a random - effects model using multiple imputation.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Discussion

When you or love one face catastrophic disease, you want to make sure you leave no stone unturned when it comes to getting the right diagnosis. One extremely reliable test is PET scan. Every year, nearly two million PET scans are performed on patients to check for diseases such as cancer, heart problems, brain orders, and conditions with the central nervous system. Pet scans are very similar to CT scans in that they provide detailed images of the body. However, unlike CT scans which show size and shape of organs and tissue, PET scans provide data at cellular level, indicating with pinpoint accuracy the exact location of issues with body. Doctors use PET scans, together with CT scans, X - rays and / or MRI to get a complete picture of what is wrong, where, and how. It is a very intricate process, so it is always good to know how these tests work so you can better understand your PET scan results.


How PET Scans Work

You may wear a gown during exam or be allowed to wear your own clothing. Women should always tell their doctor and technologist if there is any possibility that they are pregnant or they are breastfeeding. See Safety in X - ray, Interventional Radiology and Nuclear Medicine Procedures page for more information about pregnancy and breastfeeding relate to Nuclear Medicine imaging. Tell the doctor and technologist performing your exam about any medications you are taking, including vitamins and herbal supplements. List any allergies, recent illnesses and other medical conditions. You will receive specific instructions based on the type of your PET scan. Diabetic patients will receive special instructions to prepare for this exam. If you are breastfeeding at the time of the exam, ask your radiologist or doctor how to proceed. It may help to pump breast milk ahead of time and keep it on hand for use until PET radiotracer and CT contrast material are no longer in your body. Leave metal objects including jewelry, eyeglasses, dentures and hairpins at home as they may affect CT images. You may need to remove hearing aids and removable dental work. Generally, your doctor will tell you not to eat anything for several hours before the whole body PET / CT scan. Eating may alter the distribution of PET tracer in your body and can lead to suboptimal scan. This could require you to repeat the scan on another day, so following instructions regarding eating is very important. You should not drink any liquids containing sugars or calories for several hours before the scan. Instead, you are encouraged to drink water. If you are diabetic, your doctor may give you special instructions. Tell your doctor about all the medications you are taking. List any allergies, especially to contrast materials or iodine. Your doctor will check for any conditions you may have that could increase the risk of receiving intravenous contrast material.


How does the procedure work?

Ordinary x - ray exams create images by passing x - rays through the body. Nuclear medicine exams use radioactive materials called radiopharmaceuticals or radiotracer. This material is injected into the bloodstream, swallowed or inhaled as gas. Material accumulates in the area of your body under examination, where it gives off small amounts of energy in the form of gamma rays. Special cameras detect this energy and, with the help of computer, create pictures that offer details on the structure and function of organs and tissues. Unlike other imaging techniques, nuclear medicine exams focus on processes within the body, such as rates of metabolism or levels of various other chemical activity. Areas of greater intensity, called hot spots, indicate where large amounts of radiotracer have accumulated and where there is a high level of chemical or metabolic activity. Less intense areas, or cold spots, indicate smaller concentration of radiotracer and less activity. For more information on how CT scan works, see compute Tomography.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Acknowledgments

More than 200 000 new cases of Lung Cancer are diagnosed in the European Union each year. This disease is by far the most common cause of Cancer - related death in the EU. Due to an increase in smoking amongst females, increase in overall incidence is to be expected well into the first decades of the 21st century. Conventional imaging, including chest radiography, compute tomography, ultrasonography, and magnetic resonance imaging, has a major role in diagnosis, staging, and follow - up of patients with Lung Cancer. Although these imaging tests allow exquisite anatomic detail, they usually do not provide definitive diagnosis or staging. Therefore, more invasive tests with tissue sampling are often require. Positron emission tomography was initially used as a research tool for brain function studies 1 2 and assessment of cardiac metabolism 3 4. In the past 5 yrs, however, > 80% of its indications have been as innovative imaging technique in tumour patients. Different applications in Lung Cancer are listed in table 1. Use of 18 Ffluoro2deoxy - glucose - PET in respiratory Oncology is based on its ability to visualize differences between glucose metabolism of tissues. Neoplastic cells have a much higher rate of glycolysis than non - neoplastic cells and increase cellular uptake of glucose, probably due to increased expression of glucose transport proteins 5 - 8. Fdg, glucose analogue in which oxygen molecule in position 2 is replaced by positron - emitting 18 fluorine, undergoes the same uptake as glucose, but is metabolically trapped and accumulates in neoplastic cell after phosphorylation by hexokinase 9 - 11. Positron - emitting isotopes, such as 18 fluorine, have excess of protons and are therefore unstable. They decay by emission of positron, which is a subatomic, positively charge, antiparticle of negatively charged electron. Positron release in this process has kinetic energy, travels a short distance, and then annihilates with electron. This annihilation creates two 511 KEV photons, emitted in opposite directions. Detection of high numbers of these annihilations by detector rings of PET camera generates high - resolution pictures indicating sites of FDG accumulation in body 12. Preferential accumulation of FDG in neoplastic cells permits differentiation between benign and malignant tissue. In this way, FDG - PET compliments information on standard imaging with metabolic information. Illustration of reduction of radiation treatment volume when using 18 Ffluoro2deoxy - glucose positron emission tomography. According to computer tomography, malignancy is located in right upper lobe tumour T, right hilar nodes 10R, right 4R and leave 4L lower paratracheal nodes, and subcarinal ones 7. B FDG - PET correctly excludes lymph node disease in stations 7 and 10R. This reduced treatment volume by 37%. Authors want to thank numerous other coworkers involved in the 18 Ffluoro2deoxy - glucose positron emission tomography research programme of Leuven Lung Cancer Group LLCG in alphabetic order: data - nursing LLCG b. Anrys, D. Strens, nuclear Medicine p. Dupont, L. Mortelmans, S. Stroobants, pathology e. Verbeken, pneumology m. Demedts, K. Nackaerts, radiology J. Bogaert, W. De Wever, J.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Introduction

Positron emission Tomography is a medical imaging modality that enables in vivo imaging of distribution of picomolar concentrations of labelled compounds in the body. The addition of transmission compute Tomography to PET instruments results in images that provide both functional / molecular information and structural details. 18 F - label fluorodeoxyglucose is a positron emitter with a 110 - min half - life. It permits external imaging using PET and represent most widely used PET tracer. Fdg - PET was initially introduced to determine the state of physiological and pathological brain functions. Since then, it has become an established imaging modality in workup for thoracic masses, especially primary and secondary lung, pleural and mediastinal tumours. In malignant thoracic conditions, uncontrolled mitotic division of dysplastic tissue is known to be part of its long development process, and can be attributed to chronic irritation and inflammation, including that caused by noxious chemicals, parasites or chronic infection. Following the discovery of FDG as PET tracer, strength and importance of PET imaging escalated exponentially. Being glucose analogue, FDG has affinity towards glucose receptors on cell surface. Overexpression of glucose transporter 1 receptors on cancer tissue surfaces enhances glycolysis and attracts more FDG uptake, where in vivo conversion into FDG - 6phosphate by glucose - 6phosphatase takes place. The process essentially reflects increased metabolic rate of cancer cells. This process can be translated using the PET system as intense uptake of FDG, called metabolic imaging. In inflammatory and infective conditions, following exposure to aseptic or septic stimulus, cascade of response will be initiated by release of local chemokines, interleukins and prostaglandins, which are well - know pro - inflammatory mediators. This in turn will regulate the function of gate keepers in venular walls for migration of neutrophils, monocytes and effector T - cells, facilitated by perivascular macrophages and mast cells. Many authors have elucidated in detail the relationship between inflammatory response, local hyperaemia and hypervascularisation, and uptake of FDG in previous studies, supporting use of FDG - PET / CT in infection and inflammatory conditions. In chronic conditions, polymorphs, granulocytes and macrophages are predominantly involve, and the quantity of energy generated is possibly greater. In these situations, multiple cytokines and growth factors have been shown to facilitate glucose transport without increasing the number of glucose transporters by mechanism that has not been described in malignant conditions. K ubota et al. Demonstrate high accumulation of macrophages and granulation tissues surrounding abscess in animal model. Through autoradiography, this group displayed that increased FDG uptake could be found not only in tumour cells but also in inflammatory cell elements associated with growth or tumour necrosis. Increase capillary permeability at the initial stage of infection could lead to aggregation of inflammatory cells, like granulocytes, leukocytes and macrophages, at entry point. This evidence proves that FDG uptake is not specific to malignancy but is also present in infection and inflammation. In acute inflammation or infection of the chest, FDG uptake occurs primarily by activated neutrophils, whose metabolism is heavily dependent on anaerobic glycolysis, requiring elevated uptake of glucose.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Indications for PET/CT

Images acquired by PET / CT can be quite useful in evaluation of suspected or pathologically proven Lung Cancer cases, in several ways. Most common indications for PET / CT are as follow: for morphological and functional characterization of pulmonary nodules or masses; for tumor - node - metastasis staging of mediastinum and screening for metastases that might not be detected by CT alone; for radiotherapy planning; and for restaging Lung Cancer patients following treatment. In addition, PET / CT can offer insights into the histology of lesion under investigation. Previous studies evaluating preoperative maximum standardized uptake value have shown that bronchioloalveolar Carcinoma and other well - differentiate tumors are less FDG - avid than squamous cell carcinomas. Such additional characterizations can also facilitate differentiation of synchronous primary tumors from metastatic disease, as well as providing prognostic information beyond what is gathered with CT - base imaging.


How does the procedure work?

Except for intravenous injections, most nuclear medicine procedures are painless. They are rarely associated with significant discomfort or side effects. When radiotracer is given intravenously, you will feel a slight pin prick when a needle is inserted into your vein for intravenous line. You may feel cold sensation moving up your arm when a radiotracer is inject. Generally, there are no other side effects. With some procedures, catheter may be placed into your bladder. This may cause temporary discomfort. It is important to remain still during the exam. Nuclear imaging itself causes no pain. However, having to remain still or to stay in one particular position during imaging may cause discomfort. If you have fear of closed spaces, you may feel anxious during the exam. Unless your doctor tells you otherwise, you may resume your normal activities after your exam. A technologist, nurse or doctor will provide you with any necessary special instructions before you leave. A small amount of radiotracer in your body will lose its radioactivity over time through the natural process of radioactive decay. It may also pass out of your body through your urine or stool during the first few hours or days following the test. Drink plenty of water to help flush radioactive materials out of your body. For more information on what you will experience during and after the CT scan, see Computed Tomography.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Final considerations

The use of PET / CT scans has become a reliable tool that can complement and sometimes take place of conventional imaging modalities in radiological assessment of Lung Cancer. The most widely employed radiotracer, 18F - FDG, provides critical information about biological aggressiveness of tumor and corresponding prognosis. Particular attention is advised when using PET / CT in investigation of diabetic patients, as well as in regions where there is high prevalence of infectious and inflammatory conditions. For NSCLC and SCLC, PET / CT has revolutionized staging and planning of treatment. Nevertheless, radiologists and pulmonologists should become familiar with potential pitfalls that they might encounter in their interpretation of PET / CT findings.


What is a PET scan?

Positron emission tomography is an imaging test used to show how your organs and tissues are working. Whereas other imaging tests, such as X - ray, CT, and MRI, reveal structural changes in the body, PET is used to reveal chemical and physiological changes. Uses of PET scan include checking brain function; diagnosing cancer, heart problems, and brain disorders; examining blood flow to the heart; and determining the spread of cancer and response to therapy. Use of PET scans may help doctors more accurately detect the presence and location of cancer cells. Pet scan is similar to CT scan; however, PET scans can detect live cancer tissue. Prior to PET scan, patients receive injection of a substance that contains a type of sugar attached to radioactive isotope. Cancer cells take up sugar and attach isotope,s which emit positively - charge, low energy radiation. Positrons react with electrons in cancer cells, which create production of gamma rays. Gamma rays are then detected by PET machine, which transforms information into picture. If no gamma rays are detected in the scanned area, it is unlikely that the mass in question contains living cancer cells. A Pet scan can measure blood flow, oxygen use, how your body uses sugar, and much more.


WHY PET/CT?

Ct has been the cornerstone of oncologic imaging for over 20 years but lacks the ability to show crucial differences in physiology. Pet has incomparable abilities to determine metabolic activity of tissues but needs assistance of higher - resolution, information that it cannot provide. Ct is the easiest and highest - resolution tomographic modality to integrate into PET imaging. The combination of the two offers the best of both worlds in an integrated data set and thus improves diagnostic accuracy and localization of many lesions. For years, primary means of merging metabolic information with information was visual fusion, or having expert review separate PET and CT images and mentally synthesize data. More recently, software fusion has been attempted by many, utilizing specialized software programs to realign and fuse two separate sets of data. There are myriad problems with these software approaches, however, such as different positioning of patients between two studies, differences relating to breath - hold at maximal inspiration for CT versus tidal breathing during PET imaging, or even simple differences in contour of tables on two devices. The first major step toward solving this dilemma, introduced in 2000 by group of Dr. David Townsend, imaging physicist then working at the University of Pittsburgh, was to actually put two units together in one gantry. This allows for immediately sequential collection of both PET and CT data sets, with minimal potential for misregistration.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

How the Test is Performed

A PET scan requires a small amount of tracer. A Tracer is given through a vein, usually on the inside of your elbow. It travels through your blood and collects in organs and tissues. Tracers help doctors see certain areas or diseases more clearly. You will need to wait nearby as the tracer is absorbed by your body. This usually takes about 1 hour. Then, you will lie on a narrow table, which slides into a large tunnel - shape scanner. The pet scanner detects signals from tracer.S computer changes results into 3 - D pictures. Images are displayed on a monitor for your doctor to read. You must lie still during the test. Too much movement can blur images and cause errors. Pet scans are performed along with CT scan. This is because combined information from each scan provides more complete understanding of health problem. This combination scan is called PET / CT.


What is a PET scan?

Compute tomography scans use X - rays. Magnetic resonance imaging scans use magnets and radio waves. Both produce still images of organs and body structures. Pet scans use radioactive tracer to show how organ is functioning in real time. Pet scan images can detect cellular changes in organs and tissues earlier than CT and MRI scans. Your healthcare provider may perform PET scan and CT scan at same time. This combination test produces 3D images that allow for more accurate diagnosis. Some hospitals now use hybrid PET / MRI scan. This new technology creates extremely high - contrast images and can primarily be used for diagnosing and monitoring cancers of soft tissues.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Sources

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

logo

Plex.page is an Online Knowledge, where all the summaries are written by a machine. We aim to collect all the knowledge the World Wide Web has to offer.

Partners:
Nvidia inception logo

© All rights reserved
2021 made by Algoritmi Vision Inc.

If you believe that any of the summaries on our website lead to misinformation, don't hesitate to contact us. We will immediately review it and remove the summaries if necessary.

If your domain is listed as one of the sources on any summary, you can consider participating in the "Online Knowledge" program, if you want to proceed, please follow these instructions to apply.
However, if you still want us to remove all links leading to your domain from Plex.page and never use your website as a source, please follow these instructions.